Liqi Huatan Huoxue formula rescued myocardial cell apoptosis of coronary microvascular dysfunction rat by inhibiting endogenous apoptosis pathway

نویسندگان
doi
10.30498/ijb.2025.550247.4245
چکیده

Background: Coronary microvascular dysfunction (CMD) is a critical pathological condition linked to impaired myocardial perfusion and poor cardiovascular outcomes. Objectives: This study aimed to establish a CMD rat model and evaluate the therapeutic effects of the traditional Chinese medicine formula Liqi Huatan Huoxue (LQHTHX), with a focus on apoptosis, oxidative stress, and vascular endothelial function. Materials and Methods: CMD was induced in rats via intraventricular injection of sodium laurate (1 mL/kg, 1 g/L). The therapeutic efficacy of LQHTHX was assessed using hematoxylin-eosin (HE) and Masson staining, ELISA, biochemical assays, and TUNEL apoptosis assays. Western blotting (WB) and qRT-PCR were employed to evaluate the regulatory effects of LQHTHX on the NRG-1/ErbB signaling pathway and its downstream mitochondrial and endoplasmic reticulum (ER) stress pathways. Results: LQHTHX treatment improved microvascular structure and reduced thrombus obstruction in CMD rats. It enhanced antioxidant capacity, restored vascular endothelial balance, and significantly reduced cardiomyocyte apoptosis. LQHTHX modulated the NRG-1/ErbB pathway and decreased the expression of pro-apoptotic proteins (Bax, Bad, Cyt-c, Caspase-3), while increasing Bcl-2 levels. Furthermore, it suppressed ER stress-related apoptotic markers (CHOP, GRP78, Caspase-12). Conclusions: LQHTHX ameliorates CMD by inhibiting apoptosis through mitochondrial and ER stress pathways, enhancing antioxidant defenses, and protecting vascular endothelial function.